Anna Kruschinski

1 ta ish

Noxxon Pharma (Germany)

1. The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

   Julia Hoellenriegel, Dirk Zboralski, Christian Maasch +5

   MaqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.071984